[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-bcht":3},{"head":4,"company":40,"invest":45,"children":46,"shops":47,"category":48,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":13,"brandBirth":14,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":15,"status":16,"isDeleted":16,"comment":5,"remark":5,"logoExistStatus":17,"imageExistStatus":17,"industryId":5,"industryRanking":5,"score":5,"enterName":18,"mallShopList":19,"brandSummary":20,"likes":5,"unlikes":5,"follow":5,"pagetitle":21,"pagekeywords":22,"pagedesc":23,"brandContent":24,"province":5,"city":5,"area":5,"detailaddress":25,"unifiedscc":26,"enterType":27,"enterLegalperson":28,"enterStablishdate":29,"regauthority":30,"licenseValidity":31,"approvaldate":32,"regcapital":33,"incapital":34,"businessscope":35,"ownBrand":5,"enterTelphone":36,"enterWebsite":37,"business":38,"enterQq":5,"enterMail":39,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"1629961","\u002Fprofile\u002Fupload\u002F2023\u002F12\u002F02\u002F05bca9367b0cd337f3dca406d5617bb6.gif","百克生物BCHT","bcht",158436,8602,"400-8845-777","2004年","长春市",462,0,"1","长春百克生物科技股份公司",[],"成立于2004年，知名疫苗品牌，专业从事人用疫苗研发、生产、销售业务的企业，拥有完整的运营体系，产品涵盖带状疱疹减毒活疫苗、人用狂犬病疫苗、水痘减毒活疫苗等","百克生物BCHT简介-百克生物疫苗-品牌之家","百克生物BCHT品牌介绍,百克生物疫苗好不好,百克生物怎么样,百克生物,长春百克生物科技股份公司","百克生物BCHT品牌简介，品牌之家为你介绍长春百克生物科技股份公司旗下百克生物BCHT品牌信息，包括品牌介绍、联系方式、主营产品、最新评论、点赞数量等，告诉你百克生物疫苗怎么样，致力于帮助你了解百克生物BCHT真实有效的品牌相关信息。","成立于2004年，知名疫苗品牌，专业从事人用疫苗研发、生产、销售业务的企业，拥有完整的运营体系，产品涵盖带状疱疹减毒活疫苗、人用狂犬病疫苗、水痘减毒活疫苗等\n\n长春百克生物科技股份公司（以下简称“百克生物”或“公司”）是一家主要致力于传染病防治的创新生物医药企业。自2004年成立以来，主要从事人用疫苗产品的研发、生产与销售业务，通过多年发展，逐步围绕核心产品建立起完整的运营体系，对产品实行全生命周期的质量管理，包括原材料采购、项目研发、生产管理、产品流通、质量控制和质量保证，各环节均有严格的管理措施及内控制度。公司目前拥有三个厂区，总占地面积22.57万平方米，依托核心技术研发及产业化能力，具有稳定的商业模式、高度的市场认可及良好的社会形象。\n\n2021年6月，公司公开发行股票并在科创板成功上市，发行后股本总额为41,284.0698万股，发行价每股36.35元，发行股份数量占本次发行后总股本的10%，募集资金总额约15亿元。\n\n公司以产品质量为立足之本，以产品的创新研发为发展源动力，为配合企业发展战略合理设置、优化组织架构，布局研发管线全面发展。\n\n公司新型疫苗——鼻喷流感减毒活疫苗（2020年上市）是与世界卫生组织合作的、纳入WHO全球流行性流感行动计划的、国内独家的新型流感减毒活疫苗。可在短时间内提供大量疫苗产品，扩大流感疫苗市场容量，鼻腔喷雾给药，使用方便，易于大规模免疫，依从性强，对我国流感防控有重要意义。该疫苗填补了国内流感减毒活疫苗的市场空白，市场前景广阔，将是公司新的经济增长点。\n\n百克生物在研发方面一直保持着持续高强度的前期投入，打造了适用于40岁及以上人群的带状疱疹减毒活疫苗。该疫苗通过大样本三期临床试验确证安全、有效，并于2023年1月获批上市。百克生物生产的带状疱疹减毒活疫苗不仅在人群扩龄上实现了突破，也填补了国内带状疱疹疫苗的市场空白，为更多的适龄人群提供了新的预防措施。\n\n公司共有员工1252人，本科及以上学历人员711人，研发人员132人。公司非常重视高端人才的引进和培养，现本科及以上学历占员工总数的55%以上，拥有享受国务院特殊津贴专家1人，国家“新世纪百千万人才工程”1人，吉林省拔尖创新人才（一层次）3人，以及多名海外归国人员。\n\n公司由多名核心技术人员牵头，建立了一支专业稳定且有经验的研发团队。自成立以来，一直致力于生物疫苗及生物药物研发和产业化研究，目前已有水痘疫苗、冻干鼻喷流感疫苗、带状疱疹疫苗三种已获批的疫苗产品，同时还拥有13项在研疫苗和2项在研的用于传染病防控的全人源单克隆抗体，其中吸附无细胞百白破（三组分）联合疫苗和流感减毒活疫苗（液体制剂）正在开展临床研究工作、全人源抗狂犬病单克隆抗体已获得临床试验批准通知书。","高新开发区火炬路1260号","912201017561541220","其他股份有限公司(上市)","李秀峰","2004-03-04","长春市市场监督管理局高新技术产业开发区分局","-","2024-12-23","41,365.7598万(元)","37,155.6646万(元)","药物和保健食品、功能食品研究、开发及技术咨询、技术服务；预防用、治疗性生物制品研发、生产、销售，普通货物道路运输，货物专用运输（冷藏保鲜），货物及技术进出口贸易（依法须经批准的项目，经相关部门批准后方可开展经营活动）*","87078199","124.234.140.2","研究和试验发展","bcht@163.com",{"enterId":41,"enterName":18,"province":5,"city":5,"area":5,"detailaddress":25,"unifiedscc":26,"enterType":27,"enterLegalperson":28,"enterStablishdate":29,"regauthority":30,"licenseValidity":31,"approvaldate":32,"regcapital":33,"incapital":34,"businessscope":35,"ownBrand":5,"enterTelphone":36,"enterWebsite":37,"business":38,"performance":42,"socialSecurity":43,"registrationNumber":44,"enterQq":5,"enterMail":39,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":16,"regtrademark":5,"remark":5},"158436","开业","1199人","220101756154122",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[49],{"createTime":50,"updateTime":51,"createBy":5,"updateBy":5,"industryId":52,"webId":5,"industryName":53,"industryAlias":5,"industryIcon":5,"industryTrans":54,"pageTitle":55,"pageDesc":56,"pageKeywords":57,"mainTitle":58,"pageSubtitle":59,"indSummary":60,"industryLevel":61,"parentId":62,"parentName":5,"sortOrder":63,"status":16,"classifyVisit":5,"totalVisits":64,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-16 16:50:00","8602","疫苗","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002Fc5a4873d1129759bfb754af8c30ad9d2.png","十大大型疫苗公司排行榜-人用疫苗公司有哪些-ZGALL品牌榜","2026年疫苗行业十大品牌权威发布！疫苗排行榜前十名品牌有中国生物、默沙东、辉瑞、葛兰素史克、赛诺菲、智飞生物、沃森、万泰疫苗、康泰、华兰。疫苗10大品牌由品牌中国重磅推出，旨在呈现行业领域标杆品牌，展现行业优秀企业实力，帮助你了解大型疫苗公司有哪些品牌。","大型疫苗公司有哪些,大型疫苗公司排名,疫苗种类有几种厂家,中国人用疫苗企业有多少,大型疫苗公司排名前十","疫苗品牌排行榜","2026人用疫苗企业排行，大型疫苗公司排行榜，疫苗厂家有哪些","疫苗什么牌子好？品牌TOP榜权威发布2026年疫苗十大品牌名录；居前十的有：中国生物CNBG、MSD默沙东、pfizer辉瑞、GSK葛兰素史克、赛诺菲巴斯德、智飞生物ZFSW、沃森生物WALVAX、万泰疫苗INNOVAX、康泰生物、华兰疫苗等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",3,1411,99,395]